Stay updated on Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, reflecting a small maintenance update to the page without changing study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page shows a new revision tag, updating from v3.5.3 to v3.5.4, indicating a minor system update. The update does not alter the study details, eligibility criteria, or results presented on the page.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now shows a revision tag v3.5.3, with the v3.5.2 tag removed. This reflects a deployment-level update to the page rather than a substantive content change.SummaryDifference0.1%

- Check48 days agoChange DetectedUpdated the page footer revision indicator from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3, with no substantive changes to study content or layout.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.